350 related articles for article (PubMed ID: 30301855)
1. Inducible Nitric Oxide Synthase Is a Key Host Factor for
Bando H; Lee Y; Sakaguchi N; Pradipta A; Ma JS; Tanaka S; Cai Y; Liu J; Shen J; Nishikawa Y; Sasai M; Yamamoto M
mBio; 2018 Oct; 9(5):. PubMed ID: 30301855
[TBL] [Abstract][Full Text] [Related]
2.
Bando H; Lee Y; Sakaguchi N; Pradipta A; Sakamoto R; Tanaka S; Ma JS; Sasai M; Yamamoto M
Front Cell Infect Microbiol; 2019; 9():140. PubMed ID: 31119110
[No Abstract] [Full Text] [Related]
3.
Bando H; Sakaguchi N; Lee Y; Pradipta A; Ma JS; Tanaka S; Lai DH; Liu J; Lun ZR; Nishikawa Y; Sasai M; Yamamoto M
Front Immunol; 2018; 9():2073. PubMed ID: 30283439
[No Abstract] [Full Text] [Related]
4. Human innate immunity to Toxoplasma gondii is mediated by host caspase-1 and ASC and parasite GRA15.
Gov L; Karimzadeh A; Ueno N; Lodoen MB
mBio; 2013 Jul; 4(4):. PubMed ID: 23839215
[TBL] [Abstract][Full Text] [Related]
5. The
Glausen TG; Carrillo GL; Jin RM; Boyle JP; Saeij JPJ; Wohlfert EA; Fox MA; Blader IJ
mBio; 2021 Jun; 12(3):e0133121. PubMed ID: 34154412
[TBL] [Abstract][Full Text] [Related]
6.
Ihara F; Fereig RM; Himori Y; Kameyama K; Umeda K; Tanaka S; Ikeda R; Yamamoto M; Nishikawa Y
Front Immunol; 2020; 11():1709. PubMed ID: 32849602
[No Abstract] [Full Text] [Related]
7. The mechanism of interferon-gamma induced anti Toxoplasma gondii by indoleamine 2,3-dioxygenase and/or inducible nitric oxide synthase vary among tissues.
Fujigaki S; Takemura M; Hamakawa H; Seishima M; Saito K
Adv Exp Med Biol; 2003; 527():97-103. PubMed ID: 15206721
[TBL] [Abstract][Full Text] [Related]
8. L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase.
Fujigaki S; Saito K; Takemura M; Maekawa N; Yamada Y; Wada H; Seishima M
Infect Immun; 2002 Feb; 70(2):779-86. PubMed ID: 11796611
[TBL] [Abstract][Full Text] [Related]
9.
Hashizaki E; Sasai M; Okuzaki D; Nishi T; Kobayashi T; Iwanaga S; Yamamoto M
mBio; 2023 Feb; 14(1):e0325622. PubMed ID: 36715543
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ restricts Toxoplasma gondii development in murine skeletal muscle cells via nitric oxide production and immunity-related GTPases.
Takács AC; Swierzy IJ; Lüder CG
PLoS One; 2012; 7(9):e45440. PubMed ID: 23024821
[TBL] [Abstract][Full Text] [Related]
11. TgMAPK1 is a Toxoplasma gondii MAP kinase that hijacks host MKK3 signals to regulate virulence and interferon-γ-mediated nitric oxide production.
Brumlik MJ; Pandeswara S; Ludwig SM; Jeansonne DP; Lacey MR; Murthy K; Daniel BJ; Wang RF; Thibodeaux SR; Church KM; Hurez V; Kious MJ; Zhang B; Alagbala A; Xia X; Curiel TJ
Exp Parasitol; 2013 Jul; 134(3):389-99. PubMed ID: 23541881
[TBL] [Abstract][Full Text] [Related]
12. The GRA15 protein from
Wang P; Li S; Zhao Y; Zhang B; Li Y; Liu S; Du H; Cao L; Ou M; Ye X; Li P; Gao X; Wang P; Jing C; Shao F; Yang G; You F
J Biol Chem; 2019 Nov; 294(45):16494-16508. PubMed ID: 31416833
[No Abstract] [Full Text] [Related]
13. Impact of foetus and mother on IFN-gamma-induced indoleamine 2,3-dioxygenase and inducible nitric oxide synthase expression in murine placenta following Toxoplasma gondii infection.
Pfaff AW; Mousli M; Sénégas A; Marcellin L; Takikawa O; Klein JP; Candolfi E
Int J Parasitol; 2008 Feb; 38(2):249-58. PubMed ID: 17822706
[TBL] [Abstract][Full Text] [Related]
14. Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity.
Fox BA; Sanders KL; Rommereim LM; Guevara RB; Bzik DJ
PLoS Genet; 2016 Jul; 12(7):e1006189. PubMed ID: 27447180
[TBL] [Abstract][Full Text] [Related]
15. Toxoplasma gondii Matrix Antigen 1 Is a Secreted Immunomodulatory Effector.
Tomita T; Mukhopadhyay D; Han B; Yakubu R; Tu V; Mayoral J; Sugi T; Ma Y; Saeij JPJ; Weiss LM
mBio; 2021 May; 12(3):. PubMed ID: 34006649
[TBL] [Abstract][Full Text] [Related]
16. Interplay between IDO1 and iNOS in human retinal pigment epithelial cells.
Spekker-Bosker K; Ufermann CM; Oldenburg M; Däubener W; Eller SK
Med Microbiol Immunol; 2019 Dec; 208(6):811-824. PubMed ID: 31267172
[TBL] [Abstract][Full Text] [Related]
17. Evasion of Human Neutrophil-Mediated Host Defense during
Lima TS; Gov L; Lodoen MB
mBio; 2018 Feb; 9(1):. PubMed ID: 29440572
[TBL] [Abstract][Full Text] [Related]
18. Influence of Two Major
Hernández-de-Los-Ríos A; Murillo-Leon M; Mantilla-Muriel LE; Arenas AF; Vargas-Montes M; Cardona N; de-la-Torre A; Sepúlveda-Arias JC; Gómez-Marín JE
Front Cell Infect Microbiol; 2019; 9():413. PubMed ID: 31867288
[No Abstract] [Full Text] [Related]
19. Transcriptomic analysis reveals Toxoplasma gondii strain-specific differences in host cell response to dense granule protein GRA15.
Liu Q; Gao WW; Elsheikha HM; He JJ; Li FC; Yang WB; Zhu XQ
Parasitol Res; 2018 Sep; 117(9):2785-2793. PubMed ID: 29916065
[TBL] [Abstract][Full Text] [Related]
20. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
Yap GS; Sher A
J Exp Med; 1999 Apr; 189(7):1083-92. PubMed ID: 10190899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
